Publications

5808 Results

Long-Term Follow-up of an Intensive Pediatric Regimen for Adolescents/Young Adults with Ph-negative Acute Lymphoblastic Leukemia: 10-year Survival Following CALGB 10403 (Alliance)

Authors
W Silva;V Yin;M Liedtke;D Claxton;N Fulton;S Giri;G Malnassy;K Mrozek;E Paietta;C Mullighan;RA Larson;R Stone;G Uy;S Luger;A Advani;W Stock
Journal / Conference
Blood Advances 2026 May 8:bloodadvances.2026019616. doi: 10.1182/bloodadvances.2026019616
Year
2026
Research Committee(s)
Leukemia
PMID
42101912
Study Number(s)
C10403

Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study

Authors
P Gupta;K Gupta;T Dockter;E Harlos;S Chow;N Subbiah;K Ruddy;L Bazhenova;S Terstriep;C Huang;R Kratzke;E Vokes;C Loprinzi
Journal / Conference
Cancers (Basel). 2026 Jan 25;18(3):373. doi: 10.3390/cancers18030373.
Year
2026
Research Committee(s)
Symptom Management and Survivorship
PMID
41681846
PMC
PMC12896856
Study Number(s)
CTSU/A221504

DART/SWOG/NCI phase II anti- CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix

Authors
Y Chae;M Othus;S Patel;F Backes;D O'Malley;M Cristea;A Naing;K Kurnit;R Eskander;S Goodrich;W Robinson;H Kim;L Il-Young Chung;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;CD Blanke;R Kurzrock
Journal / Conference
Journal for the ImmunoTherapy of Cancer 2026 Feb 11. 14:e012805. doi:10.1136/jitc-2025-012805.
Year
2026
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
41672597
Study Number(s)
S1609

Racial and Ethnic Disparity in Preference-Weighted Quality of Life: Findings from the Selenium and Vitamin E Cancer Prevention Trial

Authors
M Rock;R Vaidya;C Till;J Unger;D Hershman;S Ramsey;A Nehemiah;D Maeng;R Krouse
Journal / Conference
Popul Health Manag. 2025 Dec;28(6):313-321. doi: 10.1089/pop.2022.0143. Epub 2023 Jan 10.
Year
2025
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID36625863
Study Number(s)
S0000

Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma

Authors
C Lao;V Ma;J Moon;J Fruehauf;L Flaherty;M Bury;W Martin;H Gross;W Akerley;J Hopkins;S Patel;V Sondak;A Ribas
Journal / Conference
Cancer 2025 Jan 1;131(1):e35587. doi: 10.1002/cncr.35587. Epub 2024 Sep 29.
Year
2025
Research Committee(s)
Melanoma
PMID
PMID39342463
PMC
PMC11694162
Study Number(s)
S0826

Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

Authors
R Banerjee;R Sexton;A Cowan;A Rosenberg;S Ailawadhi;V Rajkumar;S Kumar;S Lonial;B Durie;P Richardson;S Usmani;A Hoering;R Orlowski
Journal / Conference
Blood Jan 2;145(1):75-84
Year
2025
Research Committee(s)
Myeloma
PMID
PMID39321347
Study Number(s)
S0777, S1211

Neighborhood socioeconomic deprivation and patient-reported outcomes in symptom management trials for women with breast cancer

Authors
R Vaidya;C Till;NL Henry;M Fisch;D Hershman;J Unger
Journal / Conference
Breast Cancer Research and Treatment Feb;209(3):603-611
Year
2025
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID39560823
Study Number(s)
S0927, S1200, S1202

Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants

Authors
C Presant;R Vaidya;C Till;K Ashing;G Warren;D Hershman;V Sun;R Salgia;E Massarelli;J Mortimer;G Idos;S Pal;T Dorff;A Amini;L Erhunmwunsee;T Phillips;A Johnson;B Adesunloye;F Bedell;A Tergas;I Amanam;S Rosen;J Unger
Journal / Conference
Cancer Jan 1;131(1):e35560
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID39283236
PMC
PMC11834169

Intake and Nutritional Adequacy in Cancer Patients Diagnosed with Malignant Bowel Obstruction: A secondary analysis of a randomized trial

Authors
C Thomson;K Arnold;G Anderson;V Sun;A Secord;A Yung;M Al-Kaspooles;V Nfonsam;M Grant;G Deutsch;J Deneve;R Krouse
Journal / Conference
Journal of the Academy of Nutrition and Dietetics May;125(5):654-665.e3
Year
2025
Research Committee(s)
Palliative Care
PMID
PMID39603592
PMC
PMCIDPMC12009688
Study Number(s)
S1316

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: Vulvar Cancers

Authors
Y Chae;L Corthell;S Patel;R Edwards;J Scalici;H Kim;L Il-Young Chung;M Othus;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;C Blanke;R Kurzrock
Journal / Conference
Clinical Cancer Research Jan 17;31(2):308-315
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID39561273
PMC
PMC11804806
Study Number(s)
S1609